[Inflammatory Markers and Their Role in Assessing Prognosis of Patients With Stable Coronary Artery Disease After

D I Tomilova1, F F Byazrova1, V V Lopukhova1

  • 1Institute of Cardiology of Russian Cardiology Scientific and Production Complex, Moscow, Russia.

Kardiologiia
|March 16, 2017
PubMed

Insights

Inflammatory markers like C-reactive protein (CRP) and white blood cells are linked to cardiovascular events after stenting. Further research is needed to confirm their role in drug-eluting stent restenosis.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Biology
  • Interventional Cardiology

Context:

  • Percutaneous coronary intervention (PCI) with stent implantation is a common procedure for coronary artery disease.
  • Increased inflammatory markers have been associated with adverse cardiovascular events post-PCI.
  • The predictive value of certain inflammatory markers for restenosis, especially with drug-eluting stents, requires further investigation.

Purpose:

  • To explore the association between inflammatory markers and cardiovascular events following PCI.
  • To evaluate the role of C-reactive protein (CRP) and white blood cell count in predicting restenosis after stent implantation.
  • To investigate the potential link between eosinophilic inflammation and restenosis with drug-eluting stents.

Summary:

  • Expanded data indicate a correlation between elevated inflammatory markers and adverse cardiovascular events in patients undergoing PCI with stenting.
  • While C-reactive protein (CRP) predicts restenosis in bare metal stents, its role in drug-eluting stent restenosis is unproven.
  • Increased white blood cell counts are associated with coronary artery disease severity and poorer outcomes post-PCI.
  • Eosinophilic inflammatory responses may be linked to coronary atherosclerosis progression and drug-eluting stent restenosis.

Impact:

  • This research highlights the importance of inflammatory markers in cardiovascular risk stratification post-PCI.
  • Findings may guide future research into targeted anti-inflammatory therapies to improve outcomes after stenting.
  • Understanding these associations can lead to better prediction models for restenosis, particularly for drug-eluting stents.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
668
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
353
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.0K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
590
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
354